Please login to the form below

Not currently logged in
Email:
Password:

Ziarco

This page shows the latest Ziarco news and features for those working in and with pharma, biotech and healthcare.

Daily brief: Novartis spends big on ezcema,

Daily brief: Novartis spends big on ezcema,

Novartis already has ZPL389 in its pipeline, a phase II ezcema treatment it gained with the acquisition of Ziarco two years ago.

Latest news

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Ziarco appoints Mike Grey to board of directors Ziarco appoints Mike Grey to board of directors

    Ziarco appoints Mike Grey to board of directors. He is chairman and CEO of Reneo Pharmaceuticals. ... Ed Mathers, chairman of Ziarco, commented: “ We are thrilled to welcome Mike to Ziarco's board of directors.

  • Former Pfizer R&D head LaMattina to advise Ziarco Former Pfizer R&D head LaMattina to advise Ziarco

    Former Pfizer R&D head LaMattina to advise Ziarco. He previously spent 30 years at US pharma firm. ... UK-based biotech Ziarco has hired former head of R&D at Pfizer, Dr John LaMattina, as a strategic R&D adviser.

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

Theresa Heggie
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
Theresa Heggie talks about the biotech’s 16-year path to market, and the promise of its ‘gene silencing’ medicines...
patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...

Infographics